基本信息
views: 592
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr Kang is an expert in clinical development of new anti-cancer therapies. He has directed Clinical Research Center for several years in Asan Medical Center and has led a number of important international clinical trials. His main interests are in the treatment of gastric cancer, GIST and hepatocellular carcinoma. He has been the president of Korean Society of Medical Oncology (KSMO), the Korean Cancer Study Group (KCSG), and the Korean GIST Study Group. And he is member of many professional societies such as the Korean Cancer Society, American Society of Clinical Oncology , European Society of Medical Oncology, and the American Association of Cancer Research. He has published more than 400 papers in peer review journals.
Research Interests
Papers共 694 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Narikazu Boku,Takeshi Omori,Kohei Shitara,Shinichi Sakuramoto, Kensei Yamaguchi,Ken Kato,Shigenori Kadowaki, Kunihiro Tsuji,Min-Hee Ryu,Do-Youn Oh,Sang Cheul Oh,Sun Young Rha,
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association (2024)
Cancer research and treatmentno. 1 (2024): 199-207
Cancer research and treatmentno. 3 (2024): 743-750
Gastric Cancerpp.1-12, (2024)
Gastric Cancerno. 3 (2024): 1-12
The Lancet Gastroenterology & hepatology (2024)
Narikazu Boku,Takeshi Omori,Kohei Shitara,Shinichi Sakuramoto, Kensei Yamaguchi,Ken Kato,Shigenori Kadowaki, Kunihiro Tsuji,Min-Hee Ryu,Do-Youn Oh,Sang Cheul Oh,Sun Young Rha,
Gastric Cancerpp.1-15, (2024)
Load More
Author Statistics
#Papers: 688
#Citation: 51086
H-Index: 86
G-Index: 218
Sociability: 8
Diversity: 3
Activity: 185
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn